Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7436)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Zhu SL, Zhong JH, Ke Y, Ma L, You XM, Li LQ. Efficacy of hepatic resection |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i32/9630.htm |
| Number | Citing Articles |
| 1 |
Zi Wang, Ketao Mu, Yinzhang Lv, Lingyun Zhao, Basen Li, Yonghong Hao, Nan Wang. Efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization using CalliSpheres in treating huge hepatocellular carcinoma patients. Irish Journal of Medical Science (1971 -) 2022; 191(6): 2493 doi: 10.1007/s11845-021-02851-5
|
| 2 |
Xuhua Duan, Juanfang Liu, Xinwei Han, Jianzhuang Ren, Hao Li, Fengyao Li, Shuguang Ju. Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.793581
|
| 3 |
Masashi Fujita, Ken Okai, Manabu Hayashi, Kazumichi Abe, Atsushi Takahashi, Takashi Kimura, Akira Kenjo, Shigeru Marubashi, Yuko Hashimoto, Hiromasa Ohira. Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization. Internal Medicine 2019; 58(8): 1103 doi: 10.2169/internalmedicine.1214-18
|
| 4 |
Yongheng Deng, Shaoliang Zhu, Wen Yan, Lunan Qi, Zushun Chen, Liang Ma. Influence of clear cell carcinoma on the post-hepatectomy prognosis of patients with hepatocellular carcinoma. Future Oncology 2022; 18(5): 543 doi: 10.2217/fon-2021-0381
|
| 5 |
Hiroyasu Nishimaki, Yoji Kishi, Keiichi Akahoshi, Satoshi Nara, Minoru Esaki, Nobuyoshi Hiraoka, Kazuaki Shimada. A case of complete necrosis of a huge hepatocellular carcinoma after percutaneous transhepatic portal embolization. Kanzo 2019; 60(10): 382 doi: 10.2957/kanzo.60.382
|
| 6 |
Jinli Zheng, Ning Wang, Jingsheng Yuan, Yang Huang, Xingyu Pu, Wei Xie, Li Jiang, Jiayin Yang. The appropriate method of hepatectomy for hepatocellular carcinoma within University of California San Francisco (UCSF) criteria through neural network analysis. HPB 2023; 25(5): 497 doi: 10.1016/j.hpb.2023.02.001
|
| 7 |
Di Long, Peng-Cheng Yu, Wei Huang, Yu-Long Luo, Sen Zhang. Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer. Medicine 2016; 95(44): e5235 doi: 10.1097/MD.0000000000005235
|
| 8 |
Lei Wang, Zhiqiang Liu, Xiaolong Liu, Yongyi Zeng, Jingfeng Liu. The hepatectomy efficacy of huge hepatocellular carcinoma and its risk factors. Medicine 2017; 96(52): e9226 doi: 10.1097/MD.0000000000009226
|
| 9 |
Luke Zhou, Mao Zhang, Siyu Chen. Comparison of surgical resection and transcatheter arterial chemoembolization for large hepatocellular carcinoma: a systematic review and meta-analysis. Annals of Hepatology 2023; 28(2): 100890 doi: 10.1016/j.aohep.2022.100890
|
| 10 |
Gun Ha Kim, Jin Hyoung Kim, Ju Hyun Shim, Heung-Kyu Ko, Hee Ho Chu, Ji Hoon Shin, Hyun-Ki Yoon, Gi-Young Ko, Dong Il Gwon. Chemoembolization for Single Large Hepatocellular Carcinoma with Preserved Liver Function: Analysis of Factors Predicting Clinical Outcomes in a 302 Patient Cohort. Life 2021; 11(8): 840 doi: 10.3390/life11080840
|
| 11 |
训浩 祝. Research Progress and Prospects of Conversion Therapy for Primary Liver Cancer. Advances in Clinical Medicine 2022; 12(12): 11680 doi: 10.12677/ACM.2022.12121683
|
| 12 |
Shiro Miyayama, Yuzo Kikuchi, Masanori Yoshida, Masashi Yamashiro, Natsuki Sugimori, Rie Ikeda, Kotaro Okimura, Naoko Sakuragawa, Teruyuki Ueda, Taku Sanada, Hiroyuki Watanabe, Kazuo Notsumata. Outcomes of conventional transarterial chemoembolization for hepatocellular carcinoma ≥10 cm. Hepatology Research 2019; 49(7): 787 doi: 10.1111/hepr.13335
|
| 13 |
A. Bogdanovic, P. Bulajic, D. Masulovic, N. Bidzic, M. Zivanovic, D. Galun. Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83868-9
|
| 14 |
Nalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han Paik. Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice. Journal of Liver Cancer 2023; 23(2): 350 doi: 10.17998/jlc.2023.08.10
|
| 15 |
Zixiang Chen, Ming Cai, Xu Wang, Yi Zhou, Jiangming Chen, Qingsong Xie, Yijun Zhao, Kun Xie, Qiang Fang, Tian Pu, Dong Jiang, Tao Bai, Jinliang Ma, Xiaoping Geng, Fubao Liu. Two novel online nomograms for predicting the survival of individual patients undergoing partial hepatectomy for huge hepatocellular carcinoma. HPB 2021; 23(8): 1217 doi: 10.1016/j.hpb.2020.12.002
|
| 16 |
Andrea Chierici, Mohamed El Zibawi, Guido Liddo, Rodolphe Anty, Stefano Granieri, Patrick Chevallier, Antonio Iannelli. Multimodal treatment confers best overall survival results in patients with huge hepatocellular carcinoma: a systematic review and network meta-analysis. HPB 2024; 26(7): 895 doi: 10.1016/j.hpb.2024.04.002
|
| 17 |
Yangyang Guo, Hengyue Zhu, Min Weng, Bicheng Chen, Cheng Wang, Linxiao Sun. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration. Biomedicine & Pharmacotherapy 2020; 128: 110366 doi: 10.1016/j.biopha.2020.110366
|
| 18 |
Jeong Il Yu, Hee Chul Park. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology 2016; 22(30): 6851-6863 doi: 10.3748/wjg.v22.i30.6851
|
| 19 |
Hong In Yoon, Inkyung Jung, Kwang-Hyub Han, Jinsil Seong. The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma. Oncotarget 2016; 7(38): 62715 doi: 10.18632/oncotarget.10908
|
| 20 |
Aaron JL Lee, Andrew GR Wu, Kuo Chao Yew, Vishal G Shelat. Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis. World Journal of Gastrointestinal Surgery 2023; 15(2): 273-286 doi: 10.4240/wjgs.v15.i2.273
|
| 21 |
Lei Liang, Hao Xing, Han Zhang, Jianhong Zhong, Chao Li, Wan Yee Lau, Mengchao Wu, Feng Shen, Tian Yang. Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis. HPB 2018; 20(2): 110 doi: 10.1016/j.hpb.2017.10.004
|
| 22 |
Han Wang, Hua Yu, You-Wen Qian, Zhen-Ying Cao, Meng-Chao Wu, Wen-Ming Cong. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 232 doi: 10.1016/j.hbpd.2020.12.018
|
| 23 |
Nhan Hien Phan, Ho Jong Chun, Jung Suk Oh, Su Ho Kim, Byung Gil Choi. TACE vs. TARE for HCC ≥ 8 cm: A propensity score analysis. Abdominal Radiology 2024; doi: 10.1007/s00261-024-04573-5
|
| 24 |
Andrea Chierici, Andrew Ofosu, Ivan Cincione, Rodolfo Sacco, Christian Cotsoglou, Antonio Facciorusso. Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma?. Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 205 doi: 10.1016/j.hbpd.2020.12.005
|
| 25 |
Jinli Zheng, Xiaozhen Wei, Ning Wang, Xingyu Pu, Jiayin Yang, Li Jiang. A new method for predicting the microvascular invasion status of hepatocellular carcinoma through neural network analysis. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-01967-y
|
| 26 |
Martha M Kirstein, Nora Schweitzer, Theresa Winter, Katerina Lappas, Nathalie Graen, Isabell Kunstmann, Torsten Voigtländer, Tanja Reineke‐Plaaß, Michael P Manns, Frank Lehner, Thomas Rodt, Arndt Vogel. Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: Experience from a German referral center. Journal of Gastroenterology and Hepatology 2017; 32(10): 1730 doi: 10.1111/jgh.13761
|
| 27 |
Yue-Meng Wan, Yu-Hua Li, Zhi-Yuan Xu, Hua-Mei Wu, Ying Xu, Mei Yang, Xi-Nan Wu. The Effect of Transarterial Chemoembolization in Combination With Kang’ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study. Integrative Cancer Therapies 2018; 17(2): 477 doi: 10.1177/1534735417734913
|
| 28 |
Jesang Yu, Jinhong Jung, Sang Min Yoon. Combined Transarterial Chemoembolization and External Beam Radiotherapy in a Patient with Recurrent Huge Hepatocellular Carcinoma after Hepatic Resection. Journal of Liver Cancer 2020; 20(1): 90 doi: 10.17998/jlc.20.1.90
|
| 29 |
Zhenfeng Deng, Zongrui Jin, Yonghui Qin, Mingqi Wei, Jilong Wang, Tingting Lu, Ling Zhang, Jingjing Zeng, Li Bao, Ya Guo, Minhao Peng, Banghao Xu, Zhang Wen. Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02199-1
|